Erythrocyte fatty acid profiles in children are not predictive of autism spectrum disorder status: a case control study
Abstract Biomarkers promise biomolecular explanations as well as reliable diagnostics, stratification, and treatment strategies that have the potential to help mitigate the effects of disorders. While no reliable biomarker has yet been found for autism spectrum disorder (ASD), fatty acids have been...
Main Authors: | Daniel P. Howsmon, James B. Adams, Uwe Kruger, Elizabeth Geis, Eva Gehn, Juergen Hahn |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-03-01
|
Series: | Biomarker Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40364-018-0125-z |
Similar Items
-
New treatment perspectives in autism spectrum disorders
by: Roberto eCanitano, et al.
Published: (2015-03-01) -
Multivariate Analysis of Plasma Metabolites in Children with Autism Spectrum Disorder and Gastrointestinal Symptoms Before and After Microbiota Transfer Therapy
by: James B. Adams, et al.
Published: (2019-11-01) -
Comprehensive Nutritional and Dietary Intervention for Autism Spectrum Disorder—A Randomized, Controlled 12-Month Trial
by: James B. Adams, et al.
Published: (2018-03-01) -
Defining precision medicines approaches to Autism Spectrum Disorders: concepts and challenges
by: Eva Loth, et al.
Published: (2016-11-01) -
The Role of Cholesterol and Fatty Acids in the Etiology and Diagnosis of Autism Spectrum Disorders
by: Cecilia Maria Esposito, et al.
Published: (2021-03-01)